AI Genomics Data Analyst Interview Questions

A strong answer explains inheritance patterns, relevance to hereditary disease versus cancer, and how detection pipelines differ for each.

The candidate should walk through each column, explain genotype format subfields (GT, DP, AD, GQ), and note why VCF is the lingua franca of variant analysis.

A good answer traces the data flow: raw sequencer output (FASTQ) → read alignment (BAM), with mention of quality scores and indexing.

Expect discussion of per-base quality (Phred scores), adapter contamination, GC bias, duplication rates, and tools like FastQC and MultiQC.

The candidate should explain coordinate system mismatches, variant calling artifacts, and the recent transition to T2T-CHM13.

A thorough answer covers data preprocessing (BQSR, MarkDuplicates), HaplotypeCaller, GVCF mode, joint genotyping, and VQSR or hard filtering.

Expect mention of PCA-based diagnostics, ComBat or limma batch correction, mixed-effects models, and the importance of balanced experimental design.

A solid answer defines LD (r², D′), explains tag SNPs, haplotype blocks, fine-mapping challenges, and why a significant GWAS hit may not be causal.

The candidate should enumerate Benign, Likely Benign, VUS, Likely Pathogenic, Pathogenic, and describe how evidence streams (PVS1, PM2, PP3, etc.) are weighted.

A strong response discusses off-target reads, tools like ExomeDepth or CNVkit, normalization strategies, and validation against array CGH or PCR.

Expect discussion of SNP effect sizes from GWAS summary statistics, score calculation methods, population transferability issues, and clinical utility debates.

Analytical validity = does the test accurately detect the variant; clinical validity = does the variant reliably predict the phenotype. Both must be established before clinical utility.

Expect mention of Git, containerization (Docker/Singularity), conda environments, workflow managers (Nextflow/Snakemake), CI/CD, and pinned dependency versions.

A good answer walks through population frequency filtering, clinical assertion review, protein domain mapping, and predicted structural impact as converging evidence lines.

Expect cost-per-sample discussion, coverage depth tradeoffs, non-coding variant detection, structural variant sensitivity, and study design considerations.

A strong answer covers data curation (ClinVar assertions paired with PMIDs), tokenization of genomic entities, fine-tuning strategy, evaluation against held-out variants, and handling class imbalance.

Expect discussion of feature engineering across modalities, batch correction, multimodal fusion architectures (early/late/intermediate), TMB and neoantigen prediction, and clinical endpoint modeling.

The candidate should discuss training data bias toward common splice sites, interpretability of neural network predictions, distance-to-splice-site effects, and validation on ClinVar splice variants.

Expect discussion of in-memory databases (Redis), precomputed annotation indexes, batched API calls, caching strategies, horizontal scaling on Kubernetes, and SLA monitoring.

A thorough answer discusses improved SV detection, phasing, methylation detection, different alignment algorithms (minimap2), specialized callers (pbsv, Sniffles), and retraining ML models on long-read features.

Strong answers cover ancestry-aware training strategies, transfer learning, fairness metrics, diverse biobank recruitment, and the clinical consequences of biased polygenic risk scores.

Expect discussion of differential privacy, secure aggregation, model-splitting strategies, communication efficiency, and regulatory constraints under HIPAA/GDPR.

A strong answer discusses versioned variant databases, automated literature monitoring with NLP, alert systems for reclassification events, and audit trails for clinical reports.

Expect discussion of knowledge graph construction (STRING, BioGRID), node/edge feature engineering, GNN architectures (GAT, GraphSAGE), and evaluation against known gene-disease associations in OMIM.

The candidate should address cloud cost optimization (spot instances, tiered storage), joint calling strategies, QC at scale, summary statistics generation, and the role of centralized vs. distributed computing.

A comprehensive answer covers filtering by quality → inheritance model (de novo, recessive, X-linked) → frequency filtering (gnomAD < 0.1%) → functional impact filtering → phenotype-driven gene prioritization (HPO terms + OMIM) → literature review with AI assistance → final report.

Expect discussion of star allele nomenclature, specialized tools (Cyrius, StellarPGx), long-read sequencing for CNV resolution, phasing, and ML models for haplotype inference from short-read data.

Strong answers address patient notification, clinician communication, retrospective audit, automated ClinVar monitoring systems, and institutional review of reporting workflows.

Expect discussion of public repositories (GTEx, recount3), batch effect correction (ComBat-seq, Harmony), matched-tissue selection, confounder modeling, and validation through pathway enrichment rather than individual gene significance.

A thoughtful answer covers data auditing for representation, retraining with oversampled underrepresented populations, ancestry-stratified evaluation, fairness-aware loss functions, and transparent reporting of per-group metrics.

Expect discussion of data residency requirements, de-identification standards (Safe Harbor vs. Expert Determination), BAA with cloud provider, encryption at rest/in transit, access controls, and IRB considerations.

Strong answers address FHIR/OMOP data harmonization, genomic data model (GA4GH standards), patient identifier linkage, temporal alignment, missing data in EHR, and privacy-preserving record linkage.

Expect discussion of allele frequency detection limits, tumor purity estimation tools (ABSOLUTE, PureCN), sensitivity tuning in callers (Mutect2, Strelka2), loss-of-heterozygosity detection, and reporting of variant allele frequency alongside pathogenicity.

A strong answer covers clinical validation studies, genetic counseling integration, FDA regulatory pathway (LDT vs. IVD), informed consent design, data privacy architecture, and limitation disclosures for PRS-based risk estimates.

Expect a phased response: immediate impact assessment, automated re-annotation pipeline, prioritized clinical review for variants now meeting classification thresholds, stakeholder communication plan, and a policy for database update cadence.

Expect a detailed architecture: document chunking/embedding strategy (BioBERT vs. OpenAI embeddings), vector store selection (Pinecone, Weaviate, Chroma), retriever configuration, prompt engineering for clinical accuracy, hallucination guardrails, and evaluation metrics.

The candidate should discuss model selection (BioBERT-NER, SciSpacy), fine-tuning on annotated corpora (BC5CDR, n2c2), tokenization of biomedical entities, deployment via Inference Endpoints or custom FastAPI, and integration with downstream annotation pipelines.

A strong answer covers tool definition and chaining, memory management for context persistence, error handling for API failures, structured output parsing, and evaluation of agent reliability across diverse variant inputs.

Expect discussion of variant store vs. reference store, annotation store queries, integration with SageMaker for ML training on variant features, Lambda-triggered annotation workflows, and cost optimization with S3 lifecycle policies.

A thorough answer covers dataset curation and formatting, LoRA/QLoRA for parameter-efficient fine-tuning, instruction tuning strategy, evaluation by domain experts, and deployment considerations (quantization, serving infrastructure).

Expect mention of metrics collection (coverage depth, duplication rate, Ti/Tv ratio), time-series anomaly detection (Isolation Forest, Prophet), alerting systems (Slack/PagerDuty), Grafana dashboards, and drift detection for pipeline version changes.

A smart answer discusses prompt engineering for domain-specific code, human-in-the-loop review, test-driven development with known genomic test cases, limitations of generated code for scientific accuracy, and intellectual property considerations.

Expect discussion of Neo4j or Amazon Neptune for graph structure, vector embeddings for semantic search, hybrid search (graph traversal + vector similarity), GraphQL/REST API design, and real-world clinical query patterns.

A strong answer covers module composition, channel operators for branching workflows, process-level containerization, parameter schemas, tower.nf for monitoring, and profile configurations for different cloud backends.

Expect discussion of structured evaluation frameworks (factuality scoring against ClinVar ground truth), hallucination detection, confidence calibration, expert panel adjudication workflows, and human-in-the-loop approval gates with versioning.

The best answers demonstrate empathy, use of analogies, visual aids, iterative checking of understanding, and acknowledgment of uncertainty in genomic data.

A strong response covers immediate triage, root cause analysis, impact assessment, transparent communication to stakeholders, corrective actions, and preventive measures implemented afterward.

Expect mention of specific journals (Nature Genetics, Genome Research), preprints (bioRxiv), conferences (ASHG, RECOMB, NeurIPS workshops), community forums, and concrete application of a new method or tool.

The candidate should demonstrate scientific integrity, evidence-based communication, constructive framing of disagreement, and a resolution that maintained the relationship while upholding data standards.

A thoughtful answer covers structured onboarding, pair-programming on real projects, teaching critical evaluation of tools and literature, encouraging independent problem-solving, and creating psychological safety for asking questions.